Top Markets
#1 MowCat MowCat +49.11%
#2 Bermuda Shorts Bermuda Shorts +28.81%
#3 Velvet Velvet +25.14%
#4 Biconomy Biconomy +24.73%
#5 Quack AI Quack AI +19.77%
#6 Derive Derive +17.09%
#7 Zerebro Zerebro +13.86%
#8 Perle Perle +13.64%
#9 龙虾 (Lobster) 龙虾 (Lobster) +13.27%
#10 Playnance Playnance +12.59%
Coin of the day
MowCat MowCat
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
MyMD Pharmaceuticals, Inc. MyMD Pharmaceuticals, Inc.

MyMD Pharmaceuticals, Inc.

MYMD
Classificação em ações #35400
MyMD Pharmaceuticals, Inc. is a pharmaceutical firm currently in the clinical... MyMD Pharmaceuticals, Inc. is a pharmaceutical firm currently in the clinical development stage, focused on devising diverse therapeutic strategies that target the underlying origins of various illnesses. One of its key initiatives is the development of MYMD-1, a drug platform centered on a small molecule presently undergoing clinical trials. This molecule works by regulating the immune system to suppress TNF-alpha, a major contributor to chronic inflammation, along with other pro-inflammatory cell-signaling proteins. MYMD-1 is being explored for its potential to delay aging, extend lifespan, manage autoimmune conditions, and treat depression linked to COVID-19. Furthermore, the company is advancing Supera-CBD, a synthetic version of cannabidiol, which aims to address chronic pain, addiction, and epilepsy. MyMD Pharmaceuticals was established in 2014 and its corporate headquarters are situated in Baltimore, Maryland.
Preço da ação
$1.85
Última sincronização: 2024-08-19
Valor de mercado
$3.96M
Variação (1 dia)
2.78%
Variação (1 ano)
0.00%
País
US
Negociar MyMD Pharmaceuticals, Inc. (MYMD)

Categoria

Healthcare
EPS de MyMD Pharmaceuticals, Inc. (MYMD)
EPS em 2026 TTM: 0
De acordo com os últimos relatórios financeiros e o preço das ações da MyMD Pharmaceuticals, Inc., o EPS atual da empresa (TTM) é 0. No final de 2026, a empresa teve um EPS de 0, igual a ao EPS de 2026, que foi de 0.
Histórico de EPS da MyMD Pharmaceuticals, Inc. de 2026 até 2026
EPS no final de cada ano
Ano EPS Alterar
Não há dados suficientes para as datas fornecidas.
EPS de empresas semelhantes ou concorrentes
Empresa EPS Diferença de EPS País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE